Scailyte
About:
True precision medicine through single-cell science
Website: http://www.scailyte.com
Twitter/X: scailyte
Top Investors: Verve Ventures, Venture Kick, Innosuisse, Hemex, MassChallenge
Description:
Scailyte has established a data-driven biomarker discovery platform that leverages unique expertise in single-cell data analysis and artificial intelligence. We are utilizing this platform to discover a new class of biomarkers, which are defined by the molecular profiles of disease-associated cells. This phenotypic approach to biomarker discovery is radically new and directly related to the biology of a disease, which maximizes the success rate for discovering sensitive and robust biomarkers.
$15.5M
$1M to $10M
Basel, Basel-Stadt, Switzerland
2017-06-19
contact(AT)scailyte.com
Daniel Sonnleithner, Dennis Gohlsdorf, Manfred Claassen, Peter Nestorov
11-50
2023-12-04
Private
© 2024 MyAiNote.com